| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Feb 2025 | 10 Feb 2025 |
| Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the Un-audited financial results (Standalone and Consolidated) for the quarter and nine months ended 31.12.2024 and any other business with the permission of the Chair. the following were considered and approved: 1. Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31.12.2024. 2. Limited Review Report (standalone and consolidated) for the quarter and nine months ended 31.12.2024. (Enclosed) 3. Appointment of Mr. NSK Aakarsh Raj (DIN: 09530950) as an Additional Director (Executive category) of the Company w.e.f. 14.02.2025, subject to the approval of the shareholders in the ensuing extra ordinary general meeting. 4. Appointment of M/s. Manoj Parakh and Associates as Secretarial Auditors of the Company for the FY 2024 - 25. 5. Prior Approval of the shareholders to be taken for the Material Related Party Transactions to be entered with M/s. VSR Paper and Packaging Limited, Subsidiary of the Company. 6. Extra Ordinary General Meeting of the shareholders will be held on Friday, 14.03.2025 through video conferencing or other audio visual means for the items mentioned at sl. nos. 3 and 5 (As per BSE Announcement Dated on 14/02/2025) | ||
| Board Meeting | 14 Nov 2024 | 2 Nov 2024 |
| Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the Quarter and half year ended 30.09.2024 Results for the quarter and half year ended 30.09.2024 (As Per BSE Announcement Dated on: 14/11/2024) | ||
| Board Meeting | 4 Sep 2024 | 31 Aug 2024 |
| Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2024 inter alia to consider and approve Dividend For FY 2023-24 Board Meeting outcome for Final Dividend. 1. To pay Dividend @0.10 paisa per share to the shareholders, subject to approval of shareholders for the Financial Year 2023-24 2. Revision in the Notice and Directors Report of Annual General Meeting for the FY 2023-24. (As Per BSE Announcement Dated on 04.09.2024) | ||
| Board Meeting | 13 Aug 2024 | 6 Aug 2024 |
| Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended 30.06.2024 and any other matter with the permission of the Chair Outcome of the board meeting (As per BSE Announcement Dated on 13/08/2024) | ||
| Board Meeting | 29 May 2024 | 14 May 2024 |
| Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve AUDITED FINANCIAL RESULTS AUDIT REPORT Audited Financial results for the Quarter ended 31.03.2024 (As Per BSE Announcement Dated on 29.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
